Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures
A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures

NCT06657378

RecruitingN/A

Sponsor: Eisai Co., Ltd.

Conditions: Partial-Onset Seizures, Primary Generalized Tonic-clonic Seizures

Interventions: No Intervention

Countries: Japan

The purpose of this study is to determine the safety of Fycompa for injection after administration in participants with epilepsy (partial-onset seizures \[including secondarily generalized seizures\]) (age 4 years or older) or primary generalized tonic-clonic seizures (age 12 years or older).

Eligibility overview

Sex: ALL

Age: 4 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Participants with epilepsy who received the Fycompa for injection for the first time will be included.

Exclusion Criteria:

* The exclusion criteria will not be specified in particular because this survey will be conducted in daily clinical practice.
Locations (1)
  • Tokyo, Japan